Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Megan Marie Nelson
Post-Transplant Low-Dose Azacitidine Can Improve Overall Survival in AML/MDS Patients and Is Associated With Decrease Risks of Severe Acute and Chronic GVHD
Biology of Blood and Marrow Transplantation
Transplantation
Hematology
Related publications
Alemtuzumab Markedly Reduces Chronic GVHD Without Affecting Overall Survival in Reduced-Intensity Conditioning Sibling Allo-SCT for Adults With AML
Bone Marrow Transplantation
Transplantation
Hematology
The Influence of Stem Cell Source on Chronic-GvHD Free, Leukemia Free Transplant Survival in Pediatric Patients With Acute Myeloid Leukemia
Biology of Blood and Marrow Transplantation
Transplantation
Hematology
Phase I Dose Escalation Study of Bortezomib in Combination With Lenalidomide in Patients With Myelodysplastic Syndromes (MDS) and Acute Myeloid Leukemia (AML)
Leukemia Research
Cancer Research
Oncology
Hematology
Prolonged Responses in Patients With MDS and CMML Treated With Azacitidine and Etanercept
British Journal of Haematology
Hematology
Sequential HLA-haploidentical Transplantation Utilizing Post-Transplantation Cyclophosphamide for GvHD Prophylaxis in High-Risk and Relapsed/Refractory AML/MDS
American Journal of Hematology
Hematology
Stabilisation of Acute-On-Chronic Liver Failure Patients Before Liver Transplantation Predicts Post-Transplant Survival
Alimentary Pharmacology and Therapeutics
Hepatology
Pharmacology
Gastroenterology
Discordant Expression of AC133 and AC141 in Patients With Myelodysplastic Syndrome (MDS) and Acute Myelogeneous Leukemia (AML)
Leukemia
Cancer Research
Oncology
Anesthesiology
Pain Medicine
Hematology
CD34+ Selected Ex-Vivo T-Cell Depleted (TCD) Grafts for Allogeneic Hematopoietic Cell Transplantation (Allo-Hsct) Is Associated With Low Incidence of Acute and Chronic Graft-Versus-Host Disease (GVHD) and High Chronic-GVHD/Relapse-Free Survival
Biology of Blood and Marrow Transplantation
Transplantation
Hematology
Transplant Conditioning With Treosulfan/Fludarabine With or Without TBI. A Randomized Phase II Trial in Patients With MDS and AML
Biology of Blood and Marrow Transplantation
Transplantation
Hematology
